Literature DB >> 11113666

Parathyroid cancer: biology and management.

J B Koea1, J H Shaw.   

Abstract

A review of all reports in the literature of parathyroid carcinoma (PTC) was undertaken to define an optimal management strategy for this rare condition. PTC is uncommon and its etiology of PTC is largely unknown although patients with familial hyperparathyroidism, multiple endocrine neoplasia type 1 and irradiation to the head and neck are at increased risk for developing the disease. PTC occurs with equal frequency in both sexes and is usually diagnosed in the fifth decade. En bloc resection of the carcinoma and the adjacent structures in the neck is the surgical treatment and is associated with an 8% local recurrence rate and a long term overall survival rate of 89% (mean follow up 69 months). In contrast simple parathyroidectomy results in a 51% local recurrence rate and 53% long-term survival rate (mean follow up 62 months). Adverse prognostic factors for survival were initial management with simple parathyroidectomy alone, the presence of nodal or distant metastatic disease at presentation and non-functioning PTC.

Entities:  

Mesh:

Year:  1999        PMID: 11113666     DOI: 10.1016/s0960-7404(99)00037-7

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  49 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.

Authors:  Elias Karakas; Hans-Helge Müller; Vladimir K Lyadov; Stephanie Luz; Ralph Schneider; Matthias Rothmund; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 3.  Parathyroid cancer.

Authors:  Fiona McClenaghan; Yassar A Qureshi
Journal:  Gland Surg       Date:  2015-08

Review 4.  Best practice no 183. Examination of parathyroid gland specimens.

Authors:  S J Johnson; E A Sheffield; A M McNicol
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

5.  Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism.

Authors:  Melanie Goldfarb; Patrick O'Neal; Judy L Shih; Pamela Hartzband; James Connolly; Per-Olof Hasselgren
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

6.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

7.  Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.

Authors:  Jie Kang; Xian-Zhao Deng; You-Ben Fan; Bo Wu
Journal:  Tumour Biol       Date:  2014-04-24

8.  CT features of parathyroid carcinomas: comparison with benign parathyroid lesions.

Authors:  Koji Takumi; Yoshihiko Fukukura; Hiroto Hakamada; Hiroaki Nagano; Yuichi Kumagae; Hideo Arima; Akihiro Nakajo; Takashi Yoshiura
Journal:  Jpn J Radiol       Date:  2019-03-12       Impact factor: 2.374

9.  Hypercalcaemic encephalopathy due to metastatic parathyroid carcinoma.

Authors:  Dhalapathy Sadacharan; Shriraam Mahadevan; Jabamalai Ferdinant; Kaharin Rakeshchandru
Journal:  BMJ Case Rep       Date:  2017-05-31

Review 10.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.